- Citations, last 5 years
- 0
- Works, last 5 years
- 0
- h-index
- 15
- Scientists listed
- 0
- Grants since 2016
- 2
Grants received
2017–2018 · research · R43
Validation of SPX-101 as a candidate for the treatment of cystic fibrosis
David W Scott · Spyryx Biosciences (United States) · funded by National Institutes of Health
2017–2018 · research · R43
ENaC inhibiting peptide for Cystic Fibrosis delivered by Dry Powder Inhaler
Timothy Crowder · Spyryx Biosciences (United States) · funded by National Institutes of Health
